244 related articles for article (PubMed ID: 18480940)
1. Induction of pustular lesions during infliximab therapy for Crohn's disease.
Pérez-Pérez L; Caeiro JL; Fabeiro JM; Allegue F; Zulaica A
Acta Derm Venereol; 2008; 88(3):292-3. PubMed ID: 18480940
[No Abstract] [Full Text] [Related]
2. [Indications and results of infliximab in Crohn's disease].
Karoui S; Boubaker J; Filali A
Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
[TBL] [Abstract][Full Text] [Related]
3. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. PRO: maintenance therapy is superior to episodic therapy.
Lichtenstein GR
Am J Gastroenterol; 2005 Jul; 100(7):1433-5. PubMed ID: 15984959
[No Abstract] [Full Text] [Related]
4. Psoriasiform and pustular eruption induced by infliximab.
Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
[TBL] [Abstract][Full Text] [Related]
5. Timing infliximab therapy in pediatric Crohn's disease.
Kirschner BS; Huo D
Gastroenterology; 2007 Mar; 132(3):1167-70. PubMed ID: 17383435
[No Abstract] [Full Text] [Related]
6. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. CON: "lifetime use" is an awfully long time.
Loftus EV
Am J Gastroenterol; 2005 Jul; 100(7):1435-8. PubMed ID: 15984960
[No Abstract] [Full Text] [Related]
7. [Infliximab-induced pustular psoriasis in a patient with Crohn's disease].
Monteagudo Sánchez B; Cabanillas M; Ortiz-Marin S; Gallego-Ojea JC
Gastroenterol Hepatol; 2009 Mar; 32(3):175-6. PubMed ID: 19233516
[No Abstract] [Full Text] [Related]
8. Clinical challenges and images in GI. Oral lichenoid reaction in a patient with Crohn's disease receiving infliximab.
Moss AC; Treister NS; Marsee DK; Cheifetz AS
Gastroenterology; 2007 Feb; 132(2):488, 829. PubMed ID: 17261307
[No Abstract] [Full Text] [Related]
9. Infliximab-induced acne: report of a third case.
Sladden MJ; Clarke PJ; Mitchell B
Br J Dermatol; 2008 Jan; 158(1):172. PubMed ID: 17854357
[No Abstract] [Full Text] [Related]
10. Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing response.
Chaparro M; Panes J; García V; Mañosa M; Esteve M; Merino O; Andreu M; Gutierrez A; Gomollón F; Cabriada JL; Montoro MA; Mendoza JL; Nos P; Gisbert JP
J Clin Gastroenterol; 2011 Feb; 45(2):113-8. PubMed ID: 21242747
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for treatment with infliximab for Crohn's disease.
Hommes DW; Oldenburg B; van Bodegraven AA; van Hogezand RA; de Jong DJ; Romberg-Camps MJ; van der Woude J; Dijkstra G;
Neth J Med; 2006; 64(7):219-29. PubMed ID: 16929083
[TBL] [Abstract][Full Text] [Related]
12. [Anti-TNF (infliximab) treatment in Crohn disease: safety profile].
Carroccio A; Di Prima L; Pirrone G; Ambrosiano G; Noto D; Cefalù AB
Recenti Prog Med; 2006 Feb; 97(2):108-12; quiz 122. PubMed ID: 16671277
[TBL] [Abstract][Full Text] [Related]
13. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. A BALANCING VIEW: lifetime channeling of infliximab for crohn's disease.
Hanauer SB
Am J Gastroenterol; 2005 Jul; 100(7):1438-9. PubMed ID: 15984961
[No Abstract] [Full Text] [Related]
14. Complications of infliximab therapy in children and adolescents affected by Crohn's disease.
Diamanti A; Papadatou B; Knafelz D; Gambarara M; Ferretti F; Castro M
Am J Gastroenterol; 2003 Dec; 98(12):2812-3. PubMed ID: 14687847
[No Abstract] [Full Text] [Related]
15. Disseminated primary varicella after initiation of infliximab for Crohn's disease.
Leung VS; Nguyen MT; Bush TM
Am J Gastroenterol; 2004 Dec; 99(12):2503-4. PubMed ID: 15571606
[No Abstract] [Full Text] [Related]
16. Onset of flexural psoriasis during infliximab treatment for Crohn's disease.
Peramiquel L; Puig L; Dalmau J; Ricart E; Roe E; Alomar A
Clin Exp Dermatol; 2005 Nov; 30(6):713-4. PubMed ID: 16197398
[No Abstract] [Full Text] [Related]
17. [Pneumocystis pneumonia during infliximab treatment for active Crohn's colitis].
Minnee RC; Stokkers P; Riemens SC; Hommes DW
Ned Tijdschr Geneeskd; 2005 Oct; 149(41):2290-5. PubMed ID: 16240855
[TBL] [Abstract][Full Text] [Related]
18. Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab.
Medkour F; Babai S; Chanteloup E; Buffard V; Delchier JC; Le-Louet H
Gastroenterol Clin Biol; 2010 Feb; 34(2):140-1. PubMed ID: 20138448
[No Abstract] [Full Text] [Related]
19. Maintenance infliximab infusions forever?
Lee SD; Surawicz CM
Am J Gastroenterol; 2002 Nov; 97(11):2917-8. PubMed ID: 12425570
[No Abstract] [Full Text] [Related]
20. Colon cancer after infliximab therapy for Crohn's disease in a young patient transplanted for primary sclerosing cholangitis.
Peyrin-Biroulet L; Bressenot A; Chone L; Denjean P; Boissel P; Bigard MA; Bronowicki JP
Am J Gastroenterol; 2006 Nov; 101(11):2664-5. PubMed ID: 17090288
[No Abstract] [Full Text] [Related]
[Next] [New Search]
